Plain-English translation of NCT01005654 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects tissue samples from people who are already undergoing surgery or biopsy for endocrine tumors (tumors of the thyroid, parathyroid, adrenal gland, pancreas, and other hormone-producing glands). Researchers will analyze these samples to understand the genetic and molecular patterns that make tumors benign or cancerous, which could help doctors better diagnose and treat these conditions in the future.
Endocrine tumors are increasingly common, but they are very difficult for doctors to classify as benign or dangerous based on appearance alone. By studying the genetic blueprints and molecular signatures of these tumors, researchers hope to develop better tools to predict which tumors are truly dangerous and which need treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify, your participation will involve donating tissue samples that are collected during your scheduled surgery or biopsy—procedures you would likely be having anyway as part of your standard treatment. The study team will use these samples to perform genetic and molecular tests in the laboratory. There are no additional procedures, appointments, or medications required beyond your planned surgery or biopsy.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
United States
Enrollment target
~2,415 participants
Started
October 2009
Age range
4 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kristine J Villaruel
National Cancer Institute (NCI)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.